| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |